Literature DB >> 23876144

Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Monir Shababi1, Christian L Lorson, Sabine S Rudnik-Schöneborn.   

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive disorder that is the leading genetic cause of infantile death. SMA is characterized by loss of motor neurons in the ventral horn of the spinal cord, leading to weakness and muscle atrophy. SMA occurs as a result of homozygous deletion or mutations in Survival Motor Neuron-1 (SMN1). Loss of SMN1 leads to a dramatic reduction in SMN protein, which is essential for motor neuron survival. SMA disease severity ranges from extremely severe to a relatively mild adult onset form of proximal muscle atrophy. Severe SMA patients typically die mostly within months or a few years as a consequence of respiratory insufficiency and bulbar paralysis. SMA is widely known as a motor neuron disease; however, there are numerous clinical reports indicating the involvement of additional peripheral organs contributing to the complete picture of the disease in severe cases. In this review, we have compiled clinical and experimental reports that demonstrate the association between the loss of SMN and peripheral organ deficiency and malfunction. Whether defective peripheral organs are a consequence of neuronal damage/muscle atrophy or a direct result of SMN loss will be discussed.
© 2013 Anatomical Society.

Entities:  

Keywords:  Autonomic Nervous System; Cardiac Defects; Peripheral Organs; SMA

Mesh:

Substances:

Year:  2013        PMID: 23876144      PMCID: PMC3867883          DOI: 10.1111/joa.12083

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  148 in total

1.  Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.

Authors:  Monir Shababi; Javad Habibi; Lixin Ma; Jacqueline J Glascock; James R Sowers; Christian L Lorson
Journal:  J Mol Cell Cardiol       Date:  2012-01-17       Impact factor: 5.000

Review 2.  Neural crest stem and progenitor cells.

Authors:  Jennifer F Crane; Paul A Trainor
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

Review 3.  Spinal muscular atrophy--clinical and genetic correlations.

Authors:  K Zerres; B Wirth; S Rudnik-Schöneborn
Journal:  Neuromuscul Disord       Date:  1997-05       Impact factor: 4.296

4.  An infant with hypoplastic left heart syndrome and spinal muscular atrophy.

Authors:  Amanda L Cook; Christopher L Curzon; Angelo S Milazzo
Journal:  Cardiol Young       Date:  2006-02       Impact factor: 1.093

5.  Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.

Authors:  Ferrill F Rose; Virginia B Mattis; Hansjörg Rindt; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

6.  Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).

Authors:  S Rudnik-Schöneborn; P Stolz; R Varon; K Grohmann; M Schächtele; U-P Ketelsen; D Stavrou; H Kurz; C Hübner; K Zerres
Journal:  Neuropediatrics       Date:  2004-06       Impact factor: 1.947

7.  Cell-specific survival motor neuron gene expression during human development of the central nervous system: implications for the pathogenesis of spinal muscular atrophy.

Authors:  E F Tizzano; C Cabot; M Baiget
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  Thalamic lesions in a long-surviving child with spinal muscular atrophy type I: MRI and EEG findings.

Authors:  Yasushi Ito; Satoko Kumada; Akira Uchiyama; Kayoko Saito; Makiko Osawa; Akira Yagishita; Kiyoko Kurata; Masaharu Hayashi
Journal:  Brain Dev       Date:  2004-01       Impact factor: 1.961

9.  Neuromuscular defects in a Drosophila survival motor neuron gene mutant.

Authors:  Yick Bun Chan; Irene Miguel-Aliaga; Chris Franks; Natasha Thomas; Barbara Trülzsch; David B Sattelle; Kay E Davies; Marcel van den Heuvel
Journal:  Hum Mol Genet       Date:  2003-06-15       Impact factor: 6.150

10.  Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy.

Authors:  Amy M Avila; Barrington G Burnett; Addis A Taye; Francesca Gabanella; Melanie A Knight; Parvana Hartenstein; Ziga Cizman; Nicholas A Di Prospero; Livio Pellizzoni; Kenneth H Fischbeck; Charlotte J Sumner
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

View more
  90 in total

1.  Defects in Motoneuron-Astrocyte Interactions in Spinal Muscular Atrophy.

Authors:  Chunyi Zhou; Zhihua Feng; Chien-Ping Ko
Journal:  J Neurosci       Date:  2016-02-24       Impact factor: 6.167

2.  The Survival of Motor Neuron Protein Acts as a Molecular Chaperone for mRNP Assembly.

Authors:  Paul G Donlin-Asp; Claudia Fallini; Jazmin Campos; Ching-Chieh Chou; Megan E Merritt; Han C Phan; Gary J Bassell; Wilfried Rossoll
Journal:  Cell Rep       Date:  2017-02-14       Impact factor: 9.423

Review 3.  Disease mechanisms and therapeutic approaches in spinal muscular atrophy.

Authors:  Sarah Tisdale; Livio Pellizzoni
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

4.  Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.

Authors:  K Bey; C Ciron; L Dubreil; J Deniaud; M Ledevin; J Cristini; V Blouin; P Aubourg; M-A Colle
Journal:  Gene Ther       Date:  2017-04-20       Impact factor: 5.250

Review 5.  Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.

Authors:  Natalia N Singh; Brian M Lee; Christine J DiDonato; Ravindra N Singh
Journal:  Future Med Chem       Date:  2015-09-18       Impact factor: 3.808

6.  Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice.

Authors:  Afrooz Rashnonejad; Gholamhossein Amini Chermahini; Cumhur Gündüz; Hüseyin Onay; Ayça Aykut; Burak Durmaz; Meral Baka; Qin Su; Guangping Gao; Ferda Özkınay
Journal:  Mol Ther       Date:  2019-08-31       Impact factor: 11.454

7.  Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.

Authors:  Christian M Simon; Beatriz Blanco-Redondo; Jannik M Buettner; John G Pagiazitis; Emily V Fletcher; Josiane K Sime Longang; George Z Mentis
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

8.  Selective loss of alpha motor neurons with sparing of gamma motor neurons and spinal cord cholinergic neurons in a mouse model of spinal muscular atrophy.

Authors:  Rachael A Powis; Thomas H Gillingwater
Journal:  J Anat       Date:  2015-11-17       Impact factor: 2.610

Review 9.  Spinal muscular atrophy: journeying from bench to bedside.

Authors:  Tomoyuki Awano; Jeong-Ki Kim; Umrao R Monani
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 10.  SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities.

Authors:  Catherine E Dominguez; David Cunningham; Dawn S Chandler
Journal:  Hum Genet       Date:  2017-08-29       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.